Bernhard Mittemeyer
Corporate Officer/Principal chez Texas Tech University Health Sciences Center
Profil
Dr. Bernhard Mittemeyer, MD, is Independent Director at Hemobiotech, Inc. and a Professor-Urological Surgery at Texas Tech University Health Sciences Center.
He is on the Board of Directors at Hemobiotech, Inc.
He received his doctorate degree from Temple University (Pennsylvania).
Postes actifs de Bernhard Mittemeyer
| Sociétés | Poste | Début |
|---|---|---|
| Texas Tech University Health Sciences Center | Corporate Officer/Principal | - |
Anciens postes connus de Bernhard Mittemeyer
| Sociétés | Poste | Fin |
|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Directeur/Membre du Conseil | - |
Formation de Bernhard Mittemeyer
| Temple University (Pennsylvania) | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
